Zydus Lifesciences jumps on incorporating wholly owned subsidiary
Zydus Lifesciences is currently trading at Rs. 1139.95, up by 9.95 points or 0.88% from its previous closing of Rs. 1130.00 on the BSE.
The scrip opened at Rs. 1126.80 and has touched a high and low of Rs. 1146.25 and Rs. 1117.65 respectively. So far 59506 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1205.65 on 13-Aug-2026 and a 52 week low of Rs. 835.85 on 02-Apr-2026.
Last one week high and low of the scrip stood at Rs. 1,146.25 and Rs. 1092.75 respectively. The current market cap of the company is Rs. 1,13,710.45 crore.
The promoters holding in the company stood at 75.01%, while Institutions and Non-Institutions held 18.15% and 6.83% respectively.
Zydus Lifesciences has incorporated wholly owned subsidiary (WOS) in the name of 'Zydus Global Treasury Centre IFSC' (Gift City Company) on August 25, 2026. The said WOS has been incorporated to undertake the business of Global and / or Regional Corporate Treasury Centre and to carry out treasury activities and treasury services.
Zydus Lifesciences is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating, manufacturing, marketing and selling of finished dosage human formulations, active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
